SOD1 gene editing therapy (Trucode Gene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSOD1 gene editing therapy (Trucode Gene)
Drug Alias Namesuperoxide dismutase 1 gene editing therapy (Trucode Gene)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionSuperoxide dismutase stimulants
TargetsSuperoxide dismutase
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTrucode Gene Repair Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTrucode Gene Repair Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A